Core Points - WORK Medical Technology Group LTD has received a notification from Nasdaq granting an additional 180-calendar-day period to regain compliance with the minimum bid price requirement [1][3] - The initial notice from Nasdaq indicated that WORK Medical's stock had failed to meet the minimum bid price requirement for 30 consecutive business days, leading to an initial compliance period that expired on October 6, 2025 [2] - To regain compliance, WORK Medical's stock must achieve a minimum closing bid price of $1.00 per share for at least 10 consecutive business days during the additional compliance period [4] Company Overview - WORK Medical Technology Group LTD, through its subsidiary, is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices [5] - The company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks, and has sold products in 34 provincial-level administrative regions in China and over 30 countries worldwide [5] - WORK Medical has received quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [5]

Core Viewpoint - WORK Medical Technology Group LTD has announced a registered direct offering of 38,999,334 Class A ordinary shares at a price of $0.075 per share, aiming to raise approximately $2.9 million in gross proceeds [1][2]. Group 1: Offering Details - The offering involves the sale of Class A ordinary shares or pre-funded warrants at a purchase price of $0.075 per share, with the pre-funded warrants having an exercise price of $0.0005 per share [1]. - The transaction is expected to close on or about September 26, 2025, pending customary closing conditions [2]. - The offering is made under a shelf registration statement on Form F-3, which was declared effective by the SEC on September 15, 2025 [3]. Group 2: Company Overview - WORK Medical Technology Group LTD, through its subsidiary, develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5]. - The company has sold products in 34 provincial-level regions in China and has 15 products available in over 30 countries globally [5]. - WORK Medical has received various quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [5].

Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, operating through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and other subsidiaries [8] - The company develops and manufactures Class I and II medical devices, including customized and multifunctional masks, and sells disposable medical devices [8] - WORK Medical Technology has a diverse product portfolio comprising 21 products, with sales in 34 provincial-level administrative regions in China and exports to over 30 countries [8] - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [8] Offering Details - The company closed a registered offering, selling an aggregate of 10,000,000 ordinary units at an offering price of $0.50 per unit, resulting in gross proceeds of approximately $5 million [2][4] - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [3] - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months, and both are immediately exercisable upon issuance [3] Underwriting and Regulatory Compliance - Univest Securities, LLC acted as the sole book-running manager for the offering [4] - The offering was made pursuant to a registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission [5]

Core Viewpoint - WORK Medical Technology Group LTD has successfully closed a registered offering of 10,000,000 ordinary units at a price of $0.50 per unit, raising a total of $5.0 million before expenses [1][3]. Summary by Sections Offering Details - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [2]. - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months [2]. - The offering was conducted on a firm commitment basis, with Univest Securities, LLC serving as the sole book-running manager [4]. Use of Proceeds - Proceeds from the offering will be allocated for upgrading production equipment, investing in research and development, hiring experienced employees for compliance improvements, and general corporate purposes [3]. Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices [6]. - The company has a diverse product portfolio of 21 products, including customized masks and medical consumables, sold in 34 regions in China and over 30 countries globally [6]. - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. FDA for market entry in the U.S. [6].

Core Viewpoint - WORK Medical Technology Group LTD has announced a strategic partnership with Shanghai Chartwell Medical Device Co., Ltd. to enhance growth and innovation in the healthcare sector [1][2]. Company Overview - WORK Medical is a supplier of Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables, sold in 34 regions in China and over 30 countries globally [3]. - Shanghai Chartwell Medical specializes in high-end medical devices and consumables, offering a wide range of products across various categories, including nuclear medicine and infection control [4]. Partnership Details - The collaboration will involve Chartwell Medical's subsidiaries, including Fuying and Fufeng, focusing on mutual growth and unlocking new opportunities [2]. - The partnership aims to enhance operational efficiency, market leadership, and international competitiveness, with a goal to advance high-end medical technologies [2]. - Specific cooperation projects are expected to enrich WORK Medical's product portfolio and increase the proportion of high-value-added products, leading to substantial revenue and profit growth over the next three years [2]. Future Initiatives - The partnership may include establishing joint investment funds, potential investment in Chartwell Medical, and co-investing in key projects related to healthcare infrastructure and advanced technology [6].